Sanofi Pushing Drugs’ Added Values to Secure Patient Access amid Rising Awareness for Economic Efficiency

April 18, 2019
Kuniyuki Hara, Corporate Officer, Head of Market Access, Sanofi K.K. While the pharma industry leans on the government to look at various benefits beyond efficacy and safety in pricing medicines, the Japan arm of Sanofi S.A. is embarking on an...read more